Advancements in Diagnostic Techniques for Infectious Diseases: A Review

Katarzyna Potrawa*

Abstract

This review explores recent advancements in diagnostic techniques for infectious diseases, highlighting their impact on detection, treatment, and prevention strategies. Infectious diseases pose significant global health challenges, necessitating rapid and accurate diagnostic methods for timely intervention. Traditional diagnostic approaches often suffer from limitations such as lengthy turnaround times, low sensitivity, and the need for specialized equipment and trained personnel. However, recent developments in molecular biology, nanotechnology, and digital health have revolutionized diagnostic capabilities, enabling faster, more sensitive, and point-of-care testing options. This review provides an overview of emerging diagnostic technologies, including nucleic acid amplification assays, biosensors, microfluidics, and smartphone-based platforms. Furthermore, it discusses the potential implications of these advancements in improving disease surveillance, outbreak management, and personalized treatment strategies. By critically assessing the strengths and limitations of current diagnostic methods, this review aims to inform future research directions and foster the translation of innovative technologies into clinical practice.

Keywords

Infectious diseases • Diagnostic techniques • Molecular biology • Nanotechnology

Introduction

Infectious diseases pose significant challenges to global health, requiring timely and accurate diagnosis for effective management and control. Over the years, remarkable advancements in diagnostic techniques have revolutionized our ability to detect and identify infectious agents rapidly and with greater precision. Historically, the diagnosis of infectious diseases relied on conventional methods such as culture, microscopy, and serology. While these techniques remain valuable, they often suffer from limitations including lengthy turnaround times, low sensitivity, and the requirement for specialized expertise. However, they continue to serve as the foundation for many diagnostic algorithms and are particularly relevant in resource-limited settings [1].

Literature Review

One of the most significant advancements in recent decades has been the widespread adoption of molecular diagnostic techniques. Polymerase Chain Reaction (PCR) and its variants have revolutionized infectious disease diagnostics by enabling the rapid and sensitive detection of pathogens directly from clinical samples. Furthermore, nucleic acid amplification tests have expanded beyond PCR to include isothermal amplification methods such as loop-mediated isothermal amplification and recombinase polymerase amplification, offering advantages in terms of simplicity and portability.

Next-generation sequencing has emerged as a powerful tool for comprehensive pathogen identification and characterization. By sequencing the entire nucleic acid content of a sample, NGS enables the detection of known and novel pathogens, as well as the exploration of microbial diversity within complex samples such as microbiomes. Although initially confined to research settings, NGS technologies are increasingly being integrated into clinical practice, particularly for investigating outbreaks and cases with unclear diagnoses. Next-Generation Sequencing (NGS), also known as high-throughput sequencing, has emerged as a transformative technology in genomics, enabling the rapid and cost-effective analysis of DNA and RNA sequences. Since its inception, NGS has revolutionized various fields, including biomedical research, clinical diagnostics, agriculture, and environmental studies [2].

NGS platforms employ parallel sequencing of millions of DNA fragments, allowing for the simultaneous analysis of multiple samples at unprecedented speed and scale. The process typically involves four main steps: library preparation, template amplification, sequencing, and data analysis. During library preparation, DNA or RNA fragments are enzymatically or chemically fragmented and tagged with specific adapters for amplification and sequencing. These fragments are then amplified using PCR or other amplification methods to generate clusters of identical sequences on a solid support matrix. Finally, sequencing by synthesis or other sequencing chemistries is performed to determine the nucleotide sequence of each fragment, followed by bioinformatics analysis to assemble and interpret the sequencing data [3].

Discussion

<p>The development of rapid diagnostic tests that can be performed at the 
  point of care has revolutionized infectious disease management, especially in 
  resource-limited or remote settings. POCT devices offer advantages such as 
  simplicity, speed, and minimal infrastructure requirements. They encompass 
  a wide range of technologies including lateral flow assays, nucleic acidbased 
  assays, and biosensors, enabling rapid detection of pathogens such 
  as influenza viruses, HIV, and malaria. At its core, POCT aims to decentralize 
  diagnostic testing, shifting from centralized laboratory facilities to settings where 
  patients are seen, such as clinics, emergency departments, ambulances, and 
  even homes. POCT devices are designed to be portable, user-friendly, and 
  capable of delivering rapid results within minutes to hours, depending on the test complexity. These tests often utilize a variety of technologies, including 
  immunoassays, nucleic acid amplification, biosensors, and microfluidics, 
  tailored to specific diagnostic needs [<a href="#4" title="4">4</a>].</p>
<p>Point-of-care testing has revolutionized healthcare delivery by bringing 
  diagnostic services directly to the patient's bedside or point of care. With its 
  ability to provide rapid, accurate, and accessible diagnostic results, POCT 
  has transformed clinical practice across diverse healthcare settings, from 
  emergency departments to remote communities. By addressing challenges 
  related to quality assurance, training, regulation, data management, and costeffectiveness, 
  POCT holds immense promise for improving patient outcomes, 
  enhancing healthcare efficiency, and advancing the goal of universal access to 
  quality diagnostics. Immunological assays play a crucial role in the diagnosis 
  of infectious diseases by detecting specific antibodies or antigens produced 
  in response to infection. Enzyme-Linked Immunosorbent Assays (ELISA), 
  lateral flow immunoassays, and immunofluorescence assays are among 
  the commonly used techniques. Recent advancements in assay design and 
  multiplexing capabilities have enhanced sensitivity and specificity, enabling the 
  simultaneous detection of multiple pathogens in a single sample [<a href="#5" title="5">5</a>]. </p>
<p>The integration of biosensors and nanotechnology has led to the 
  development of innovative diagnostic platforms with enhanced sensitivity, 
  specificity, and portability. Nanomaterials such as nanoparticles and 
  nanowires are being utilized for the immobilization of biomolecules and signal 
  amplification, while microfluidic devices enable precise manipulation of samples 
  and reagents. These technologies hold promise for ultra-sensitive and rapid 
  detection of infectious agents at the point of care. Biosensors, coupled with 
  nanotechnology, represent a cutting-edge fusion of biology and engineering, 
  enabling the development of highly sensitive and selective devices for realtime 
  detection and monitoring of biological and chemical analytes. </p>
<p>Biosensors are analytical devices that integrate a biological sensing 
  element (such as enzymes, antibodies, or nucleic acids) with a physicochemical 
  transducer (such as optical, electrochemical, or piezoelectric) to convert 
  biological recognition events into measurable signals. The interaction between 
  the target analyte and the biological receptor generates a signal proportional 
  to the concentration of the analyte, allowing for quantitative or qualitative 
  analysis. Biosensors offer advantages such as high specificity, rapid response, 
  portability, and compatibility with miniaturization. Despite the significant 
  progress in diagnostic techniques for infectious diseases, several challenges 
  remain. These include the need for cost-effective solutions, standardization 
  of assays, and access to advanced technologies in resource-limited settings. 
  Moreover, the ongoing emergence of antimicrobial resistance and novel 
  pathogens underscores the importance of continuous innovation in diagnostic 
  approaches [<a href="#6" title="6">6</a>].</p>
 

Conclusion

<p>Advancements in diagnostic techniques have transformed the landscape of infectious disease diagnosis, enabling rapid and accurate detection of 
  pathogens with implications for patient care, outbreak management, and 
  public health surveillance. By leveraging molecular, immunological, and 
  nanotechnological approaches, the field continues to evolve, offering new 
  opportunities to combat infectious diseases effectively. Continued investment 
  in research and development is essential to address remaining challenges and 
  ensure the accessibility and affordability of advanced diagnostic technologies 
  worldwide.</p>

Acknowledgement

<p>None.</p>

Conflict of Interest

<p>None.</p>

References

<ol>
  <li><a name="1" id="1"></a>Ting, Darren Shu       Jeng, Jessica Cairns, Bhavesh P. Gopal and Charlotte Shan Ho, et al.       &quot;<a href="https://www.frontiersin.org/articles/10.3389/fmed.2021.715118/full" target="_blank">Risk factors, clinical outcomes, and       prognostic factors of bacterial keratitis: The Nottingham Infectious       Keratitis Study</a>.&quot; <em>Front Med</em> 8 (2021): 715118.
    <p align="right"><a href="https://scholar.google.com/scholar_lookup?title=Risk+Factors,+Clinical+Outcomes,+and+Prognostic+Factors+of+Bacterial+Keratitis:+The+Nottingham+Infectious+Keratitis+Study&amp;author=Ting,+D.S.J.&amp;author=Cairns,+J.&amp;author=Gopal,+B.P.&amp;author=Ho,+C.S.&amp;author=Krstic,+L.&amp;author=Elsahn,+A.&amp;author=Lister,+M.&amp;author=Said,+D.G.&amp;author=Dua,+H.S.&amp;publication_year=2021&amp;journal=Front.+Med.&amp;volume=8&amp;pages=715118&amp;doi=10.3389/fmed.2021.715118&amp;pmid=34458289" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.3389/fmed.2021.715118" target="_blank"><u>Crossref</u></a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/34458289" target="_blank"><u>Indexed at</u></a></p>
  </li>
  <li><a name="2" id="2"></a>Hoffman, Jeremy J.,       John KG Dart, Surjo K. De and Nicole Carnt, et al. &quot;<a href="https://www.nature.com/articles/s41433-021-01812-7" target="_blank">Comparison of culture, confocal microscopy and       PCR in routine hospital use for microbial keratitis diagnosis.</a>&quot; <em>Eye</em> 36 (2022): 2172-2178.
    <p align="right"><a href="https://scholar.google.com/scholar_lookup?title=Comparison+of+culture,+confocal+microscopy+and+PCR+in+routine+hospital+use+for+microbial+keratitis+diagnosis&amp;author=Hoffman,+J.J.&amp;author=Dart,+J.K.G.&amp;author=De,+S.K.&amp;author=Carnt,+N.&amp;author=Cleary,+G.&amp;author=Hau,+S.&amp;publication_year=2022&amp;journal=Eye&amp;volume=36&amp;pages=2172%E2%80%932178&amp;doi=10.1038/s41433-021-01812-7&amp;pmid=34741122" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.1038/s41433-021-01812-7" target="_blank"><u>Crossref</u></a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/34741122" target="_blank"><u>Indexed at</u></a></p>
  </li>
  <li><a name="3" id="3"></a>Wang, Ye Elaine,       Tudor Cosmin Tepelus, Laura A. Vickers and Elmira Baghdasaryan, et al.       &quot;<a href="https://link.springer.com/article/10.1007/s10792-019-01134-4" target="_blank">Role of in vivo confocal microscopy in the       diagnosis of infectious keratitis.</a>&quot; <em>Int       Ophthalmol</em> 39 (2019): 2865-2874.
    <p align="right"><a href="https://scholar.google.com/scholar_lookup?title=Role+of+in+vivo+confocal+microscopy+in+the+diagnosis+of+infectious+keratitis&amp;author=Wang,+Y.E.&amp;author=Tepelus,+T.C.&amp;author=Vickers,+L.A.&amp;author=Baghdasaryan,+E.&amp;author=Gui,+W.&amp;author=Huang,+P.&amp;author=Irvine,+J.A.&amp;author=Sadda,+S.&amp;author=Hsu,+H.Y.&amp;author=Lee,+O.L.&amp;publication_year=2019&amp;journal=Int.+Ophthalmol.&amp;volume=39&amp;pages=2865%E2%80%932874&amp;doi=10.1007/s10792-019-01134-4&amp;pmid=31209694" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.1007/s10792-019-01134-4" target="_blank"><u>Crossref</u></a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/31209694" target="_blank"><u>Indexed at</u></a></p>
  </li>
  <li><a name="4" id="4"></a>Curro&#8208;Tafili,       K., F. D. Verbraak, R. de Vries and R. M. A. van Nispen, et al. &quot;<a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/opo.13238" target="_blank">Diagnosing and monitoring the characteristics       of Acanthamoeba keratitis using slit scanning and laser scanning <em>in vivo</em> confocal       microscopy</a>.&quot; <em>Ophthalmic Physiol Opt</em> 44 (2024):       131-152.
    <p align="right"><a href="https://scholar.google.com/scholar_lookup?title=Diagnosing+and+monitoring+the+characteristics+of+Acanthamoeba+keratitis+using+slit+scanning+and+laser+scanning+in+vivo+confocal+microscopy&amp;author=Curro-Tafili,+K.&amp;author=Verbraak,+F.D.&amp;author=de+Vries,+R.&amp;author=van+Nispen,+R.M.A.&amp;author=Ghyczy,+E.A.E.&amp;publication_year=2023&amp;journal=Ophthalmic+Physiol.+Opt.&amp;volume=44&amp;pages=131%E2%80%93152&amp;doi=10.1111/opo.13238&amp;pmid=37916883" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.1111/opo.13238" target="_blank"><u>Crossref</u></a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/37916883" target="_blank"><u>Indexed at</u></a></p>
  </li>
  <li><a name="5" id="5"></a>Zhang, Yuheng,       Xizhan Xu, Zhenyu Wei and Kai Cao, et al. &quot;<a href="https://www.sciencedirect.com/science/article/pii/S1876034123001016" target="_blank">The global epidemiology and clinical diagnosis       of Acanthamoeba keratitis.</a>&quot; <em>J Infect Public Heal</em> (2023).
    <p align="right"><a href="https://scholar.google.com/scholar_lookup?title=The+global+epidemiology+and+clinical+diagnosis+of+Acanthamoeba+keratitis&amp;author=Zhang,+Y.&amp;author=Xu,+X.&amp;author=Wei,+Z.&amp;author=Cao,+K.&amp;author=Zhang,+Z.&amp;author=Liang,+Q.&amp;publication_year=2023&amp;journal=J.+Infect.+Public+Health&amp;volume=16&amp;pages=841%E2%80%93852&amp;doi=10.1016/j.jiph.2023.03.020&amp;pmid=37030037" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.1016/j.jiph.2023.03.020" target="_blank"><u>Crossref</u></a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/37030037" target="_blank"><u>Indexed at</u></a></p>
  </li>
  <li><a name="6" id="6"></a>Li, Suxia, Jiang       Bian, Yuting Wang and Shuting Wang, et al. &quot;<a href="https://www.nature.com/articles/s41433-019-0482-3" target="_blank">Clinical features and serial changes of       Acanthamoeba keratitis: an <em>in vivo</em> confocal microscopy study</a>.&quot; <em>Eye</em> 34 (2020): 327-334.
    <p align="right"><a href="https://scholar.google.com/scholar_lookup?title=Clinical+features+and+serial+changes+of+Acanthamoeba+keratitis:+An+in+vivo+confocal+microscopy+study&amp;author=Li,+S.&amp;author=Bian,+J.&amp;author=Wang,+Y.&amp;author=Wang,+S.&amp;author=Wang,+X.&amp;author=Shi,+W.&amp;publication_year=2019&amp;journal=Eye&amp;volume=34&amp;pages=327%E2%80%93334&amp;doi=10.1038/s41433-019-0482-3&amp;pmid=31292523" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.1038/s41433-019-0482-3" target="_blank"><u>Crossref</u></a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/31292523" target="_blank"><u>Indexed at</u></a></p>
  </li>
</ol>